| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $28K | — |
| R&D Expense | $6.0M | -10.2% |
| SG&A Expense | $7.5M | -12.4% |
| Operating Income | -$13.5M | +11.6% |
| Income Tax | $0 | — |
| Net Income | -$14.3M | -9.9% |
| EPS (Basic) | -$0.34 | +32.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | -33.5% |
| Short-term Investments | $14.5M | — |
| Current Assets | $20.9M | +121.9% |
| Total Assets | $29.7M | +63.0% |
| Current Liabilities | $3.8M | +43.9% |
| Total Liabilities | $12.7M | +23.9% |
| Stockholders' Equity | $17.0M | +112.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | +10.4% |
| Investing Cash Flow | -$14.3M | -479.4% |
| Financing Cash Flow | $22.7M | +88.8% |